Loading organizations...
Loading organizations...
Cell engineering company developing transformative stem cell treatments.
Vita Therapeutics has raised $63.0M across 2 funding rounds.
Vita Therapeutics has raised $63.0M in total across 2 funding rounds.
Vita Therapeutics has raised $63.0M in total across 2 funding rounds.
Vita Therapeutics's investors include James Peyer, Dennis J. "Chip" Wilson, Cedars-Sinai Medical Center, Riptide Ventures, TEDCO, Early Light Ventures, Kiwoom Bio, SCM Life Sciences.
Vita Therapeutics has raised $63.0M across 2 funding rounds. Most recently, it raised $31.0M Series B in October 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 12, 2022 | $31.0M Series B | James Peyer, Dennis J. "Chip" Wilson | Cedars-Sinai Medical Center, Riptide Ventures, TEDCO |
| Jun 23, 2021 | $32.0M Series A | James Peyer | Early Light Ventures, Kiwoom Bio, SCM Life Sciences |